Peter Kuehl1, 2, 13, Jiong Zhang2, 3, 13, Yvonne Lin4, Jatinder Lamba5, Mahfoud Assem5, John Schuetz5, Paul B. Watkins6, Ann Daly7, Steven A. Wrighton8, Stephen D. Hall9, Patrick Maurel10, Mary Relling5, Cynthia Brimer5, Kazuto Yasuda5, Raman Venkataramanan11, Stephen Strom12, Kenneth Thummel4, Mark S. Boguski2
& Erin Schuetz51
Department of Molecular and Cell Biology, University of Maryland at Baltimore, Baltimore, Maryland, USA.
2
National Center for Biotechnology Information, National Institute of Health, Bethesda, Maryland, USA.
3
McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University, Baltimore, Maryland, USA.
4
Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.
5
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
6
University of North Carolina, Chapel Hill, North Carolina, USA.
7
Department of Pharmacological Sciences, University of Newcastle Upon Tyne, Newcastle, UK.
8
Department of Drug Metabolism, Eli Lilly & Co., Indianapolis, Indiana, USA.
9
Department of Clinical Pharmacology, Indiana University, Indianapolis, Indiana, USA.
10
INSERM, Montpellier, France.
11
Department of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
12
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
13
These authors contributed equally to this work.
Correspondence should be addressed to Erin Schuetz erin.schuetz@stjude.org
